Latest Financial Results
Q1 2022
Quarter Ended Mar 31, 2022
$263.3M
Q1 total revenue of $263.3 million, up 50% from $176.1 million for the prior-year quarter
$12.1M
Q1 net income of $12.1 million, compared to $14.5 million for the prior-year quarter
$14.3M
Q1 net income attributable to ApolloMed of $14.3 million, up 8% from $13.2 million for the prior-year quarter
For complete information regarding our financials, see our periodic filings